Abstract

Recently, the DAD study group reported an increased risk for myocardial infarction (MI) in HIV-infected patients with longer duration of antiretroviral therapy containing protease inhibitors (PIs), particularly lopinavir and indinavir (JW AIDS Clin Care Feb 1 2010). However, due to the limited follow-up period at the time of the previous report, …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call